Skip to content

Advertisement

You're viewing the new version of our site. Please leave us feedback.

Learn more

BMC Urology

Open Access
Open Peer Review

This article has Open Peer Review reports available.

How does Open Peer Review work?

miRNAs associated with prostate cancer risk and progression

  • Hung N. Luu1, 2,
  • Hui-Yi Lin3,
  • Karina Dalsgaard Sørensen4,
  • Olorunseun O. Ogunwobi5,
  • Nagi Kumar6,
  • Ganna Chornokur6,
  • Catherine Phelan6,
  • Dominique Jones7,
  • LaCreis Kidd7,
  • Jyotsna Batra8,
  • Kosj Yamoah6, 9,
  • Anders Berglund10,
  • Robert J. Rounbehler11,
  • Mihi Yang12,
  • Sang Haak Lee13,
  • Nahyeon Kang13,
  • Seung Joon Kim13,
  • Jong Y. Park6Email author and
  • Giuliano Di Pietro6, 14
BMC UrologyBMC series – open, inclusive and trusted201717:18

https://doi.org/10.1186/s12894-017-0206-6

Received: 14 September 2016

Accepted: 2 March 2017

Published: 20 March 2017

Back to article

Open Peer Review reports

Pre-publication versions of this article and author comments to reviewers are available by contacting info@biomedcentral.com.

Original Submission
14 Sep 2016 Submitted Original manuscript
29 Oct 2016 Reviewed Reviewer Report - Kenneth Iczkowski
6 Nov 2016 Reviewed Reviewer Report - Stefan Ambs
17 Nov 2016 Reviewed Reviewer Report - Badar Mian
3 Jan 2017 Author responded Author comments - Hung Luu
Resubmission - Version 2
3 Jan 2017 Submitted Manuscript version 2
Publishing
2 Mar 2017 Editorially accepted
20 Mar 2017 Article published 10.1186/s12894-017-0206-6

How does Open Peer Review work?

Open peer review is a system where authors know who the reviewers are, and the reviewers know who the authors are. If the manuscript is accepted, the named reviewer reports are published alongside the article. Pre-publication versions of the article and author comments to reviewers are available by contacting info@biomedcentral.com. All previous versions of the manuscript and all author responses to the reviewers are also available.

You can find further information about the peer review system here.

Authors’ Affiliations

(1)
Division of Epidemiology, Department of Medicine, Vanderbilt Epidemiology Center, Vanderbilt-Ingram Cancer Center, Vanderbilt University School of Medicine
(2)
Department of Epidemiology and Biostatistics, College of Public Health, University of South Florida
(3)
Biostatistics Program, School of Public Health, Louisiana State University Health Sciences Center
(4)
Department of Molecular Medicine, Aarhus University Hospital
(5)
Department of Biological Sciences, Hunter College of The City University of New York
(6)
Department of Cancer Epidemiology, H. Lee Moffitt Cancer Center and Research Institute
(7)
Department of Pharmacology and Toxicology, James Brown Cancer Center, University of Louisville School of Medicine
(8)
Australian Prostate Cancer Research Centre-QLD, Institute of Health and Biomedical Innovation and School of Biomedical Sciences, Translational Research Institute, Queensland University of Technology
(9)
Department of Radiation Oncology, H. Lee Moffitt Cancer Center and Research Institute
(10)
Department of Biostatistics and Bioinformatics, H. Lee Moffitt Cancer Center and Research Institute
(11)
Department of Tumor Biology, H. Lee Moffitt Cancer Center and Research Institute
(12)
Research Center for Cell Fate Control, College of Pharmacy, Sookmyoung Women’s University
(13)
Department of Internal Medicine, The Cancer Research Institute, College of Medicine, The Catholic University of Korea
(14)
Department of Pharmacy, Federal University of Sergipe, Rodovia Marechal Rodon

Advertisement